Clincosm LogoSign in Get a demo

Lung Cancer

Showing NaN - NaN of 202
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Microbial and Host Signatures During Immunotherapy for Lung

Recruiting
  • Lung Cancer
  • Bronchoscopy
  • Research Procedures
  • New York, New York
    NYU Langone Health
Jun 28, 2022

Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

Active, not recruiting
  • Breast Cancer
  • +10 more
  • Los Angeles, California
  • +7 more
Jun 21, 2022

Lung Cancer Trial in New York, Philadelphia (HRHA, LRLA, HRLA)

Completed
  • Lung Cancer
  • HRHA
  • +3 more
  • New York, New York
  • +1 more
Jun 22, 2022

Lung Cancer, Unresectable Mesothelioma Trial in United States (Pembrolizumab, Image-guided cryoablation)

Recruiting
  • Lung Cancer
  • Unresectable Mesothelioma
  • Basking Ridge, New Jersey
  • +6 more
Jun 15, 2022

Lung Cancer Trial in United States (panitumumab, carboplatin, paclitaxel)

Completed
Has Results
  • Lung Cancer
  • Carmichael, California
  • +30 more
May 23, 2022

WTC Chest CT Imaging Archive

Active, not recruiting
  • Chronic Airway Disease
  • +2 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jun 9, 2022

    Lung Cancer Trial in Canada, United States (SBRT 40.0 Gy, SBRT 42.5 Gy, SBRT 45.0 Gy)

    Completed
    Has Results
    • Lung Cancer
    • SBRT 40.0 Gy
    • +8 more
    • Peoria, Arizona
    • +57 more
    May 23, 2022

    Genetic Susceptibility to Lung Cancer in Never Smokers

    Active, not recruiting
    • Lung Cancer
    • Questionaire, blood sample
    • Questionaire, Blood sample
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Jun 7, 2022

    Lung Cancer, Lung Cancer Stage I, Lung Cancer Stage II Trial in Mission Viejo, New York (CivaSheet)

    Recruiting
    • Lung Cancer
    • +2 more
    • CivaSheet
    • Mission Viejo, California
    • +2 more
    May 23, 2022

    Breast Cancer, Bladder Cancer, Kidney Cancer Trial in New York (PCR/PCR/LDR Strategy)

    Recruiting
    • Breast Cancer
    • +6 more
    • PCR/PCR/LDR Strategy
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Apr 1, 2022

    Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)

    Completed
    • Colorectal Cancer (CRC)
    • +10 more
    • San Francisco, California
    • +16 more
    Mar 30, 2022

    Non Small Cell Lung Cancer, Lung Cancer, Nsclc Trial in United States (Radiation Therapy, Durvalumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • +4 more
    • Miami, Florida
    • +8 more
    Mar 30, 2022

    Lung Cancer Biomarkers and Screening

    Recruiting
    • Lung Cancer
      • New York, New York
        NYU Cancer Institute at New York University Medical Center
      Feb 28, 2022

      Lung Cancer Trial in Worldwide (Itacitinib, Osimertinib)

      Active, not recruiting
      • Lung Cancer
      • La Jolla, California
      • +30 more
      Mar 8, 2022

      Solid Tumor Cancers, Lung Cancer, Bladder Cancer Trial in United States (ado-trastuzumab emtansine)

      Recruiting
      • Solid Tumor Cancers
      • +3 more
      • ado-trastuzumab emtansine
      • Basking Ridge, New Jersey
      • +6 more
      Mar 1, 2022

      Lung Cancer Trial in New York (mAb hu3S193)

      Completed
      Has Results
      • Lung Cancer
      • monoclonal antibody hu3S193
      • New York, New York
        Memorial Sloan-Kettering Cancer Center
      Feb 7, 2022

      Lung Cancer Trial in New York (GL-ONC1)

      Active, not recruiting
      • Lung Cancer
      • GL-ONC1
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Feb 7, 2022

      Lung Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Placebo)

      Completed
      Has Results
      • Lung Cancer
      • Nivolumab
      • +2 more
      • Sacramento, California
      • +195 more
      Jan 25, 2022

      Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

      Recruiting
      • Advanced Cancer
      • +9 more
      • COM701
      • COM701 with Opdivo (Nivolumab).
      • Los Angeles, California
      • +10 more
      Jan 25, 2022

      New York Female Asian Nonsmoker Screening Study (FANSS)

      Recruiting
      • Lung Cancer
        • New York, New York
          NYU Langone Health
        Dec 7, 2021

        Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

        Active, not recruiting
        • Brain and Central Nervous System Tumors
        • +9 more
        • DNA analysis
        • +4 more
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Oct 28, 2021

        Colorectal Cancer, Pancreatic Cancer, Lung Cancer Trial in Brooklyn, New York (Vitamin C)

        Recruiting
        • Colorectal Cancer
        • +2 more
        • Vitamin C
        • Brooklyn, New York
        • +1 more
        Sep 22, 2021

        EGFR Gene Mutation, Lung Cancer, Lung Cancer Metastatic Trial in United States (Dacomitinib, Osimertinib)

        Recruiting
        • EGFR Gene Mutation
        • +2 more
        • Basking Ridge, New Jersey
        • +7 more
        Aug 27, 2021

        Lung Cancer, Untreated Stage IV or Recurrent Squamous Cell Lung Cancers Trial in United States (albumin-bound paclitaxel,

        Completed
        Has Results
        • Lung Cancer
        • Untreated Stage IV or Recurrent Squamous Cell Lung Cancers
        • Miami, Florida
        • +5 more
        Dec 21, 2020

        Lung Cancer Trial in Worldwide (Standard Radiation Dose Therapy, cisplatin, etoposide)

        Active, not recruiting
        • Lung Cancer
        • Standard Radiation Dose Therapy
        • +4 more
        • Birmingham, Alabama
        • +933 more
        Jan 8, 2021